Skip to main content
SpringerLink
Log in

Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas

  • Oncology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Matrix metalloproteinases (MMPs) that have a proteolytic activity against the components of extracellular matrix (ECM) play an important role in the invasive and metastatic spread of tumors. The role of MMPs and tissue inhibitors of MMPs (TIMPs) in laryngeal squamous cell carcinoma (LSCC) has not been elucidated sufficiently. The aim of the present study was to evaluate the correlation between the expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and TIMP-1, as well as the clinicopathological features of LSCCs. The expression of collagenases and TIMP-1 was examined immunohistochemically in 50 cases of surgically obtained specimens of primary LSCCs. Analyses indicated that LSCC cells as well as stromal cells expressed MMP-1, MMP-13 and TIMP-1 immunostaining. Overexpression of TIMP-1 occurred more frequently in non-metastasizing cases ( P =0.009). TIMP-1 and MMP-1 staining correlated significantly with the histologic type of LSCC. The keratinizing type of carcinomas exhibited higher TIMP-1 protein expression than the nonkeratinizing variety ( P =0.01). TIMP-1 staining was associated with the grade of differentiation, since it was found predominantly in well and moderately differentiated carcinomas ( P =0.04). The findings confirm that expression of analyzed MMPs and TIMP-1 is characteristic of LSCC and that these enzymes contribute to the progression of tumors. TIMP-1 upregulation might exhibit lower metastatic potential in LSCCs and is linked rather with an early stage of tumor progression. It seems also that TIMP-1 expression is dependent on the grade of differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ariola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kriniemi AL, Keski-Oja J, Saarialho-Kee UK (1999) Expression of collagenase-1 and -3 and their inhibitors TIMP-1 and TIMP-3 correlates with level of invasion in malignat melanomas. Br J Cancer 80: 733–743

    Article  PubMed  Google Scholar 

  2. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C (1999) Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 107: 45–47

    CAS  PubMed  Google Scholar 

  3. Cazorla M, Hernandez L, Nadal A, Balbin M, Lopez JM, Vizoso F (1998) Collagenase-3 overexpression is associated with advanced local invasion in human squamous cell carcinoma of the larynx. J Pathol 186: 144–150

    CAS  PubMed  Google Scholar 

  4. Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB (1997) Expression of matrix metalloproteinases and tissue inhibitor of metaloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 106: 271–278

    CAS  PubMed  Google Scholar 

  5. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766

    CAS  PubMed  Google Scholar 

  6. Gomez DE, Alonso DF, Yoshiji H (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111–115

    PubMed  Google Scholar 

  7. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M (1998) In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102: 2002–2010

    PubMed  Google Scholar 

  8. Hayakawa T, Yamashita K, Tanzawa K (1992) Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett 298: 29–35

    CAS  PubMed  Google Scholar 

  9. Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, Shi YE (2001) Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 61: 2365–2370

    CAS  PubMed  Google Scholar 

  10. Jiang Y, Goldberg ID, Shi YE (2002) Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245–2252

    Article  CAS  PubMed  Google Scholar 

  11. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinoma of the head and neck. Am J Pathol 151: 499–508

    CAS  PubMed  Google Scholar 

  12. Kameyama K (1996) Expression of MMP-1 in the capsule of thyroid cancer-realationship with invasiveness. Pathol Res Pract 192: 20

    CAS  PubMed  Google Scholar 

  13. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K (1999) Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627

    Article  CAS  PubMed  Google Scholar 

  14. Lynch CC, Lynn MM (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561–573

    Article  CAS  PubMed  Google Scholar 

  15. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121

    CAS  PubMed  Google Scholar 

  16. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H (1991) Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumor. Int J Cancer 48: 550–556

    CAS  PubMed  Google Scholar 

  17. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185: 256

    Article  CAS  PubMed  Google Scholar 

  18. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 522: 55

    Google Scholar 

  19. Nii M, Kayada Y, Yoshiga K, Takada K, Okamoto T, Yanagihara K (2000) Suppression of metastasis by tissue inhibitor of metalloproteinase-1 in a newly established human oral squamous cell carcinoma cell line. Int J Oncol 16: 119–124

    CAS  PubMed  Google Scholar 

  20. O-charoenrat P, Rhys-Evans PH, Eccles SA (2001) Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813

    CAS  PubMed  Google Scholar 

  21. Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P (1991) Detection of mRNA encoding collagenase I and stromelysin 2 in carcinoma of the head and neck by situ hybridization. Invasion Metastasis 11: 76–83

    CAS  PubMed  Google Scholar 

  22. Sawatsuashi M, Mizokami H, Tokunaga O, Shin T (1998) Expression of MMP-1, TIMP-1 and type I collagen in laryngeal carcinoma. Mod Pathol 11: 878

    PubMed  Google Scholar 

  23. Shanmugaratnum K (1991) Histological typing of tumors of the upper respiratory tract and ear: in collaboration with L.H. Sobin and pathologist in eight countries, 2nd edn. Springer Tokyo Berlin Heidelberg New York

    Google Scholar 

  24. Stahle-Backdahl M, Sandstendt B, Bruce K, Lindahl A, Jimenez MG (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 76: 717–728

    CAS  PubMed  Google Scholar 

  25. Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103: 1237–1241

    CAS  PubMed  Google Scholar 

  26. Westermarck J, Kahari V (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781–792

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Wroclaw Medical University, Chalubinskiego Street 2, 51-268, Wroclaw, Poland

    Tomasz Krecicki, Marcin Fraczek & Tomasz Zatonski

  2. Department of Embryology and Histology, Wroclaw Medical University, Wroclaw, Poland

    Marzena Podhorska

  3. Department of Pathological Anatomy, Wroclaw Medical University, Wroclaw, Poland

    Michal Jelen & Teresa Szkudlarek

  4. Smolenskiego 4, 51-607 , Wroclaw, Poland

    Tomasz Krecicki

Authors
  1. Tomasz Krecicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcin Fraczek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michal Jelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marzena Podhorska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teresa Szkudlarek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomasz Zatonski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomasz Krecicki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krecicki, T., Fraczek, M., Jelen, M. et al. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 260, 494–497 (2003). https://doi.org/10.1007/s00405-003-0610-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-003-0610-2

Keywords

Search

Navigation